日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy

用于癌症免疫治疗中阿霉素和抗PD-L1肽共递送的一体化乙二醇壳聚糖纳米颗粒

Sukyung Song ,Man Kyu Shim ,Suah Yang ,Jaewan Lee ,Wan Su Yun ,Hanhee Cho ,Yujeong Moon ,Jin Young Min ,Eun Hee Han ,Hong Yeol Yoon ,Kwangmeyung Kim

Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death

用于靶向癌症免疫疗法的抗PD-L1肽偶联前药纳米颗粒,结合了PD-L1阻断和免疫原性细胞死亡。

Yujeong Moon ,Man Kyu Shim ,Jiwoong Choi ,Suah Yang ,Jinseong Kim ,Wan Su Yun ,Hanhee Cho ,Jung Yeon Park ,Yongju Kim ,Joon-Kyung Seong ,Kwangmeyung Kim

Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death

用于癌症治疗的载阿霉素 PLGA 纳米粒子:PLGA 分子量对阿霉素释放控制免疫原性细胞死亡的影响

Yongwhan Choi, Hong Yeol Yoon, Jeongrae Kim, Suah Yang, Jaewan Lee, Ji Woong Choi, Yujeong Moon, Jinseong Kim, Seungho Lim, Man Kyu Shim, Sangmin Jeon, Ick Chan Kwon, Kwangmeyung Kim